AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Neuronetics, Inc. Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SSSWY7
2.11▲ 0.03 (1.44%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
2.08
Day's Range
2.02 – 2.18
52-Week Range
1.12 – 3.44
Volume
600.3K
Avg Volume
1.0M
Share Statistics
Shares Outstanding
Employees
658
Exchange
XNAS
Listed
2018-06-28
Share count as of August 5, 2026

Neuronetics, Inc. Common Stock (STIM) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Neuronetics, Inc. Common Stock (STIM)
What is Neuronetics, Inc. Common Stock's Market Cap?
Neuronetics, Inc. Common Stock's Market Cap is $160.8M, based on as-reported figures from SEC (XBRL) filings.
What is Neuronetics, Inc. Common Stock's Enterprise Value?
Neuronetics, Inc. Common Stock's Enterprise Value is $203.1M, based on as-reported figures from SEC (XBRL) filings.
What is Neuronetics, Inc. Common Stock's Price / Sales?
Neuronetics, Inc. Common Stock's Price / Sales is 1.0×, based on as-reported figures from SEC (XBRL) filings.
What is Neuronetics, Inc. Common Stock's EV / Revenue?
Neuronetics, Inc. Common Stock's EV / Revenue is 1.3×, based on as-reported figures from SEC (XBRL) filings.
What is Neuronetics, Inc. Common Stock's EV / EBITDA?
Neuronetics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Neuronetics, Inc. Common Stock's Revenue (TTM)?
Neuronetics, Inc. Common Stock's Revenue (TTM) is $155.1M, based on as-reported figures from SEC (XBRL) filings.
What is Neuronetics, Inc. Common Stock's Net Income (TTM)?
Neuronetics, Inc. Common Stock's Net Income (TTM) is -$30.4M, based on as-reported figures from SEC (XBRL) filings.
What is Neuronetics, Inc. Common Stock's EBITDA?
Neuronetics, Inc. Common Stock's EBITDA is -$19.7M, based on as-reported figures from SEC (XBRL) filings.
What is Neuronetics, Inc. Common Stock's Diluted EPS (TTM)?
Neuronetics, Inc. Common Stock's Diluted EPS (TTM) is -0.40, based on as-reported figures from SEC (XBRL) filings.
What is Neuronetics, Inc. Common Stock's EBITDA Margin?
Neuronetics, Inc. Common Stock's EBITDA Margin is -12.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · STIMAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Consolidated Statements of Operations
Total revenue—
YoY growth+9.1%—+85.7%+101.3%
Total cost of revenues—
Gross profit—
% of revenue51.1%—52.0%45.9%
Operating expenses:
Sales and marketing—
General and administrative—
Research and development—
Total operating expenses—
% of revenue54.7%—64.0%65.5%
Loss from operations—
% of revenue-3.6%—-12.1%-19.6%
Other (income) expense:
Interest expense—
Loss on extinguishment of debt————
Other income, net—
Net loss
% of revenue-8.3%—-17.2%-25.2%
Less: Net gain (loss) attributable to non-controlling interest—
Net loss attributable to Neuronetics stockholders—
% of revenue-8.3%—-17.1%-24.3%
Net loss per share of common stock outstanding, basic attributable to Neuronetics stockholders (in dollars per share)—
Net loss per share of common stock outstanding, diluted attributable to Neuronetics stockholders (in dollars per share)—